Deal Watch: AstraZeneca/Almirall And Pfizer/Baxter Vaccines Deal Change Math On Future Pfizer/AstraZeneca Bid
Executive Summary
Meda acquires family-owned Italian firm Rottapharm for $3.1 billion, expanding its European and emerging markets business. Boehringer Ingelheim and Zealand sign their second collaboration, this time around peptide candidates for cardio-metabolic disease.